Evaluation of an in vitro dialysis system to predict drug removal

Nephrology Dialysis Transplantation

Volumn 19, Issue 2, 2004, Pages 400-405

  Hudson, Joanna Q ^a   Comstock, Thomas J ^b   Feldman, George M ^b,c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Dialysis; Drug removal; Haemodialysis; Pharmacokinetics; Vancomycin

Indexed keywords

POLY(METHYL METHACRYLATE); POLYSULFONE; VANCOMYCIN;

ADULT; AGED; ARTICLE; ARTIFICIAL KIDNEY; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION COEFFICIENT; DIALYSATE; DIALYSIS MEMBRANE; DRUG CLEARANCE; FEMALE; FLOW RATE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; IN VITRO STUDY; IN VIVO STUDY; KIDNEY FAILURE; MALE; MOLECULAR WEIGHT; PREDICTION; PRIORITY JOURNAL; REFERENCE VALUE; RELIABILITY; STATISTICAL SIGNIFICANCE;

ADULT; AGED; DIALYSIS SOLUTIONS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; PREDICTIVE VALUE OF TESTS; PROBABILITY; RENAL DIALYSIS; SENSITIVITY AND SPECIFICITY; VANCOMYCIN;

EID: 1042292025     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg550     Document Type: Article

References (19)

1. DeSoi CA, Sahm DF, Umans JG. Vancomycin elimination during high-flux hemodialysis: kinetic model and comparison of four membranes: Am J Kidney Dis 1992; 4: 354-360
2. Brunet S, Leblanc M, Geadah D, Parent D, Courteau S, Cardinal J. Diffusive and convective solute clearances during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates. Am J Kidney Dis 1999; 34: 486-492
3. Keller F, Wilms H, Schultze G, Offerman G, Molzahn M. Effect of plasma protein binding, volume of distribution and molecular weight on the fraction of drugs eliminated by hemodialysis. Clin Nephrol 1983; 19: 201-205
4. Lanese DM, Alfrey PS, Molitoris BA. Markedly increased clearance of vancomycin during hemodialysis using polysulfone dialyzers. Kidney Int 1989; 35: 1409-1412
5. Pallone TL, Hyver S, Petersen J. The simulation of continuous arteriovenous hemodialysis with a mathematical model. Kidney Int 1989; 35: 125-133
6. Spivey JM, Blum RA, Nix DE. Mathematic modeling of drug disposition and postdialysis rebound inpatients requiring hemodialysis. Pharmacotherapy 1992; 12; 201-206
7. c) clearance through dialyzers. Biopharm Drug Dispos 1995; 16: 23-35
8. Hatton RC, Portales IT, Finlay A, Ross EA. Removal of iron dextran by hemodialysis: an in vitro study. Am J Kidney Dis 1995; 26: 327-330
9. Ash SR, Gloeckner PJ, Barnett SL. Lack of removal of calcitriol during hemodialysis procedures. J Am Soc Nephrol 1997; 8: 1587-1591
10. Membrana Dialyzer Database. www.membrana.de/haemodialysis/dialysedatabase/center.htm. May 5, 2003
11. Foote EF, Dreitlein WB, Steward CA, Kapoian T, Walker JA, Sherman RA. Pharmacokinetics of vancomycin when administered during high flux hemodialysis. Clin Nephrol 1998; 32: 1284-1289
12. Pollard TA, Lampasona V, Akkerman S et al. Vancomycin redistribution: dosing recommendations following high-flux hemodialysis. Kidney Int 1994; 45: 232-237
13. Touchette MA, Patel RV, Anandan JV, Dumler F, Zarowitz BJ. Vancomycin removal by high-flux polysulfone hemodialysis membranes in critically ill patients with end-stage renal disease. Am J Kidney Dis 1995; 26: 469-474
14. Morita K, Yamiji A. Changes in the serum protein binding of vancomycin in patients with methicillin-resistant staphylococcus aureus infection: the role of serum alpha 1-acid glycoprotein levels. Ther Drug Monit 1995; 17: 107-112
15. Tan CC, Lee HS, Ti TY, Lee EJ. Pharmacokinetics of intravenous vancomycin in patients with end-stage renal failure. Ther Drug Monit 1990; 12: 29-34
16. Quale JM, O'Halloran JJ, De Vincenzo N, Barth RH. Removal of vancomycin by high-flux hemodialysis membranes. Antimicrob Agents Chemother 1992; 36: 1424-1426
17. Langsdorf LJ, Krankel LG, Zydney AL. Effect of bloodmembrane interactions on solute clearance during hemodialysis. ASAIO J 1993; 39: M767-M772
18. Cigarran-Guldris S, Brier ME, Golper TA. Tobramycin clearance during simulated CAVHD. Contrib Nephrol 1991; 93: 120-123
19. Eloot S, De Wachter D, Vienken J, Pohlmeier R, Verdonck P. In vitro evaluation of the hydraulic permeability of polysulfone dialysers. Int J Artif Organs 2002; 25: 210-216